Immediate Impact
2 by Nobel laureates 11 from Science/Nature 69 standout
Citing Papers
CDK4 and CDK6 kinases: From basic science to cancer therapy
2022 StandoutScience
Targeting replication stress in cancer therapy
2022 Standout
Works of Christopher L. Sorge being referenced
Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christopher L. Sorge | 149 | 60 | 130 | 206 | 8 | 412 | |
| Graeme C. M. Smith | 122 | 55 | 151 | 194 | 8 | 489 | |
| Shwu-Huey Liu | 105 | 30 | 136 | 227 | 9 | 461 | |
| How Sung Lee | 108 | 54 | 35 | 188 | 18 | 480 | |
| B. Kevin Park | 90 | 64 | 151 | 146 | 15 | 472 | |
| Ma’an Amad | 47 | 75 | 100 | 234 | 8 | 479 | |
| D. Runge | 140 | 67 | 137 | 148 | 19 | 501 | |
| Jean‐Marc Bégué | 81 | 63 | 196 | 102 | 11 | 405 | |
| Amanda Garrido | 73 | 92 | 24 | 207 | 11 | 482 | |
| Elizabeth Galloway | 40 | 88 | 31 | 193 | 12 | 413 | |
| Dominique Fokan | 93 | 67 | 55 | 228 | 11 | 500 |
All Works
Loading papers...